Explore High Cholesterol Hyperlipidemia Clinical Trials for Alternative Management!
Regular cholesterol-lowering medications might not help everyone reduce their blood cholesterol. We are investigating a novel therapy that may help lower low-density lipoprotein cholesterol (LDL-C) which is not controlled by lipid-modifying therapy. Your participation may help us achieve this.
Hyperlipidemia or high blood cholesterol is directly linked to atherosclerosis. Atherosclerosis is the gradual buildup of plaque inside the arteries which may lead to obstruction in the blood flow to vital organs like the heart or brain. This can lead to serious life-threatening complications like a heart attack or stroke. Prime Revival Research Institute conducts High Cholesterol Hyperlipidemia Clinical Trials to help lower low-density lipoprotein cholesterol (LDL-C) levels.
You may be able to participate if you:
- Are male or female and ≥18 years of age
- Have a history of ASCVD (MI, PCR, CABG, Stroke)
- Coronary calcium score >100 Agatston units within 6 months prior to screening
- Are on maximally tolerated lipid-modifying therapy
- Statin at a maximally tolerated stable dose
- Have a fasting serum LDL-C 55 mg/dL (1.4 mmol/L) to <100 mg/dL (<2.6 mmol/L)
- *Additional criteria may apply.
To see if you qualify for this research study, your doctor will review additional study criteria. If you do qualify and participate in the High Cholesterol Hyperlipidemia Clinical Trials, you will receive all study-related care.
*There is no cost to you or your private medical insurance to participate in the Hyperlipidemia Clinical Trials. You will receive monetary compensation for your time and travel. And all participants receive study-related care from doctors & health care professionals, free of cost.
*If you think you may be eligible to participate in the Hyperlipidemia Clinical Trials or would like more information, please enter your information so we can see if you may qualify and can contact you about the study.